Contribution: Industrial Research Assistance Program – Contributions to Firms
Eupraxia Pharmaceuticals Inc.
$924,000.00
Advanced Development of Antibiotic Film Product for Post-Surgical Infections
FY 2018-19 · 2019-02-01
Summary
Development of a sustained-release, antibiotic drug product that is more effective than the current treatments for the prophylactic prevention of post-surgical infections will be advanced through preclinical studies towards clinical trials.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Victoria|Victoria, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
818717308
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2019-02-01 | 2018-19 | $999,000.00 |
| 1 | 2019-02-01 | 2018-19 | $924,000.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The total amended value is -75,000 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La valeur totale des modifications est de - 75 000 dollars.
Agreement End Date
2020-07-31
Agreement Number
923765
Agreement Start Date
2019-02-01
Agreement Title
Advanced Development of Antibiotic Film Product for Post-Surgical Infections
Agreement Title (French)
Développement avancé d'une pellicule antibiotique pour les infections post-chirurgicales
Agreement Type
Contribution
Agreement Value
$924,000.00
Amendment Date
2019-12-13
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Development of a sustained-release, antibiotic drug product that is more effective than the current treatments for the prophylactic prevention of post-surgical infections will be advanced through preclinical studies towards clinical trials.
Description (French)
Le développement d'un produit médicamenteux antibiotique à libération prolongée, plus efficace que les traitements actuels pour la prévention prophylactique des infections post-chirurgicales, sera poursuivi par des études précliniques et des essais cliniques.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Victoria
Federal Riding (French)
Victoria
Federal Riding Number
59041
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
818717308
Recipient City
Victoria|Victoria
Recipient Country
CA
Recipient Legal Name
Eupraxia Pharmaceuticals Inc.
Recipient Postal Code
V8R 5J2
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2018-2019-Q4-923765
